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product. All patients except one were HBeAg-negative and
anti-HBe-positive. The only patients with HBeAg-positive
showed genotype D and had a previously seroconversion
but latter had a new reactivation. About risk factors for
HBV acquisition, in half of cases was unknown; in the other
half there was sexual (21.4%), transfusion (14.3%), maternal
(7.1%) or interfamilial (7.1%) transmission.
Conclusions: These result showed that genotype D is the
most prevalent accompanied with genotype A in chronically
infected patients in our hospital. Moreover, we did not found
any evidence about HBeAg state and identiﬁed genotype.
doi:10.1016/j.ijid.2008.05.1236
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Background: HCV comprises a heterogeneous family of
viruses, with at least six genotypes and countless subtypes.
HCV infection is a public health problem worldwide, includ-
ing in Brazil. The World Health Organization estimates that
approximately 3% of the Brazilian population is infected
with HCV. Identiﬁcation of the HCV genotype is important
for epidemiology, prognosis, and determining the course of
treatment for the infection; there is data that suggests a
poorer prognosis and the need for more aggressive therapy
for genotype 1.
Objective: Determine the prevalence of different HCV
genotypes in the population of the city of Brasilia, the
national capital.
Methods: A retrospective, cross-sectional study was con-
ducted with a population of 213 individuals, comprising
128 men and 85 women between the ages of 21 and 81,
who underwent genotyping for HCV in Sabin laboratories
between 2005 and 2007. Repeat cases were excluded from
the study. Detection of viral RNA in the plasma was obtained
by the nested-RT-PCR technique and genotyping by the RFLP
technique.
Results and Conclusion: Genotype 1 was observed in 149
individuals (70%), genotype 3 in 53 individuals (25%), geno-
type 2 in 9 individuals (4%), and genotype 4 in 2 individuals
(1%). Subtypes 5 and 6 were not found in this population.
The results obtained in the Federal District population are
similar to those published in other states in the Southeast
and Northeast regions of Brazil and to the distribution of
HCV genotypes in the western world.
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Background: About, two billion people in the world have
been infected by Hepatitis B virus (HBV), 350 million of
whom are chronic carriers of the virus. Occult hepatitis
B virus (HBV) infection is characterized by presence of
HBV infection with undetectable hepatitis B surface antigen
(HBsAg). Diagnosis of occult HBV infection requires sensi-
tive HBV-DNA polymerase chain reaction (PCR)assay. Scanty
information is available about the etiology of viral chronic
diseases in the United Arab Emirates (UAE). Therefore a
study was carried out for detecting and genotyping of Hep-
atitis B Virus (HBV) in patients with chronic liver diseases
(CLD) as well as determining the prevalence of occult HBV
in CLD patients in the UAE.
Methods: A total of 248 serum samples from CLD patients
and 139 healthy individuals were tested by polymerase
chain reaction (PCR) in determining DNA in serum samples.
Liver biopsies were taken from randomly selected 71 HBV
infection from CLD patients were tested by immunohisto-
chemistry ((IHC) staining for HBsAg and HBcAg. Genotyping
of HBV-DNA was carried out by commercial kit.
Results: The results indicated the prevalence of HCV,
HBV, Mixed (HBV & HCV) and Occult HBV infections at a
rate of 51.2%, 31.8%, 4.0%, and 8.9% in CLD patients respec-
tively. On the other hand Healthy subjects were found to be
positive for HBV at a rate of 2.9% (P = 0.001). Themost preva-
lent genotypes of HBV infection in CLD patients were D and
E (60.6% & 26.8.0% respectively). Whereas the prevalence
of other genotypes (B, C and A) were in the range of 3.8%,
1.9% and 0.9% respectively. IHC results of randomly selected
71 CLD patients with HBV revealed that 98.6% (70/71), of
the liver biopsies were positive for HbsAg & HbcAg whereas
95.8% (68/71) of the serum samples and liver biopsies among
occult HBV patients with CLD were positive for HBV-DNA
by PCR. Histopathological studies of liver biopsies revealed
that patients with HBV infection were more likely to have
necroinﬂammatory activity and ﬁbrosis than patients with-
out HBV infection.
Conclusion: Occult HBV is relatively frequent among
patients with CLD in UAE. It may be associated with
more advanced liver pathology and more aggressive clinical
course. Genotype D appears to be the dominant genotype
circulating in UAE population with CLD. Genotypes C and
A appeared to be the minor genotypes. IHC staining could
be of a help in the diagnosis of occult HBV in CLD patients
beside PCR.
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